Emmaus Life Sciences, Inc.
EMMA
$0.07
$0.019.23%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.53M | 12.03M | 12.45M | 11.89M | 13.99M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.53M | 12.03M | 12.45M | 11.89M | 13.99M |
| Cost of Revenue | 994.00K | 800.00K | 857.00K | 931.00K | 1.08M |
| Gross Profit | 14.54M | 11.23M | 11.60M | 10.96M | 12.92M |
| SG&A Expenses | 9.75M | 10.66M | 11.05M | 11.27M | 13.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.98M | 11.64M | 12.22M | 12.62M | 15.08M |
| Operating Income | 4.55M | 388.00K | 231.00K | -728.50K | -1.09M |
| Income Before Tax | -5.43M | -8.49M | -7.48M | -7.29M | -3.97M |
| Income Tax Expenses | 598.00K | 9.00K | 9.00K | -1.00K | -581.00K |
| Earnings from Continuing Operations | -6.02 | -8.50 | -7.49 | -7.29 | -3.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.02M | -8.50M | -7.49M | -7.29M | -3.39M |
| EBIT | 4.55M | 388.00K | 231.00K | -728.50K | -1.09M |
| EBITDA | 4.61M | 437.00K | 270.00K | -699.50K | -1.07M |
| EPS Basic | -0.09 | -0.13 | -0.12 | -0.11 | -0.05 |
| Normalized Basic EPS | -0.04 | -0.08 | -0.07 | -0.06 | -0.04 |
| EPS Diluted | -0.10 | -0.13 | -0.12 | -0.12 | -0.06 |
| Normalized Diluted EPS | -0.05 | -0.08 | -0.07 | -0.06 | -0.04 |
| Average Basic Shares Outstanding | 268.80M | 262.48M | 256.16M | 255.46M | 255.46M |
| Average Diluted Shares Outstanding | 319.15M | 262.48M | 256.16M | 255.46M | 255.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |